Navigation Links
CMS Proposes Permanent Medicare Payment for VisionCare's Telescope Implant for Macular Degeneration
Date:7/9/2013

SARATOGA, Calif., July 9, 2013 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., today announced the Centers for Medicare and Medicaid Services (CMS) has proposed to provide reimbursement for VisionCare's Implantable Miniature Telescope (by Dr. Isaac Lipshitz), the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), in 2014. The announcement was included as part of CMS' CY 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) Payment System proposed rule.

According to the proposal, CMS would assign the telescope implant procedure (CPT® code* 0308T) to a new Ambulatory Payment Classification (APC) 0351, Level VII Anterior Segment Eye Procedures, with mean cost calculated using claims data available for the final rule. If finalized, the new APC would be effective January 1, 2014.

"We are encouraged by CMS' proposal to create a new clinical APC for the telescope implant procedure beginning in January 2014 to solidify patient access," said Allen W. Hill, CEO of VisionCare, "Over the course of the last year, VisionCare has provided important data to CMS on the cost and use of the device to treat patients with severe vision loss due to end-stage AMD." 

At present, the telescope implant procedure is reimbursed under a transitional pass-through payment mechanism that will expire on December 31, 2013.  VisionCare is continuing to analyze this proposal and intends to submit comments to CMS as part of the rate-setting process.

About the CentraSight Treatment Program

The first-of-kind telescope implant is integral to a new patient care program, CentraSight, for patients with end-stage macular degeneration. The CentraSight treatment program involves a patient management process and access to reimbursement information for patients and physicians. The telescope implantation is performed by a specially trained ophthalmic surgeon as an outpatient procedure.

Patients and physicians can find more information about the telescope implant and related treatment program at www.CentraSight.com or 1-877-99-SIGHT.

About the Telescope Implant

The Implantable Miniature Telescope (by Dr. Isaac Lipshitz) is indicated for monocular implantation to improve vision in patients greater than or equal to 75 years of age with stable severe to profound vision impairment (best-corrected distance visual acuity 20/160 to 20/800) caused by bilateral central scotomas (blind areas) associated with end-stage AMD. This level of visual impairment constitutes statutory (legal) blindness. Smaller than a pea, the telescope is implanted in one eye in an outpatient surgical procedure. In the implanted eye, the device renders enlarged central vision images over a wide area of the retina to improve central vision, while the non-operated eye provides peripheral vision for mobility and orientation.

The risks and benefits associated with the telescope implant are discussed in the Patient Information Booklet available at www.CentraSight.com.

About VisionCare

VisionCare Ophthalmic Technologies, Inc., headquartered in Saratoga, CA, is a privately-held company focused on development, manufacturing, and marketing of implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. VisionCare's Implantable Miniature Telescope was invented by company founders Yossi Gross and Isaac Lipshitz. Information on VisionCare can be found at www.visioncareinc.net.

*CPT copyright 2013 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.


'/>"/>
SOURCE VisionCare Ophthalmic Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Proposes Unique Device Identification Regulations for Medical Devices
2. Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
3. Kaiser Permanente Study Finds Varied Reasons Why Patients Do Not Fill their Initial Statin Prescriptions
4. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
5. Doug Bonacum of Kaiser Permanente Named to List of 50 Experts Leading the Field of Patient Safety
6. Kaiser Permanente Receives Award for Excellence in Medication Safety
7. Kaiser Permanente Members Share Stories of Survival for Februarys Heart Health Month
8. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
9. Kaiser Permanente Joins Rock Health to Support Digital Innovation in Health Care
10. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
11. Four Million People Choose Connectivity and Convenience with Kaiser Permanentes Personal Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen ... HIV-Selbsttests  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The cerebrospinal fluid (CSF) acts as ... is circulated though the brain and its ventricles, the spine and the ... the brain changes significantly. As a result, intracranial ...
(Date:11/30/2016)...  Millennium Dental Technologies, Inc. announced that it has again ... of the State of California , County ... California,s Uniform Trade Secrets act, Unfair ... practices which are untrue and misleading, as well as other ... the second time in three years that Millennium found it ...
Breaking Medicine Technology:
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... ... 2016 , ... "I hate when the mixture of saliva and toothpaste runs ... inventor from Bridgewater, N.J. "I thought that there had to be a way to ... the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For Discovery, ... the opening of a new eating disorder treatment center location in Palm Beach ... adults and adolescents, both males and females ages 10 and older with eating ...
(Date:11/30/2016)... MA (PRWEB) , ... November 30, 2016 , ... ... for treating injured workers have been a focus of public policymakers and system ... Compensation Research Institute (WCRI) released its Medical Price Index for Workers’ Compensation, ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Clinical Data Interchange Standards ... Binding Guidance goes into effect next month. Sponsors whose studies start after December ... Standards Catalog. The current FDA Data Standards Catalog specifies the use of CDISC ...
Breaking Medicine News(10 mins):